Applies to influenza virus vaccine, h5n1: intramuscular suspension.

General

The most common adverse events were injection site pain, muscle aches, and irritability.^[Ref]

Local

Very common (10% or more): Injection site pain (83%), injection site erythema (33.7%), injection site swelling (28.6%)

Common (1% to 10%): Injection site pruritus, injection site warmth

Uncommon (0.1% to 1%): Injection site reaction^[Ref]

Musculoskeletal

Very common (10% or more): Muscle aches (45%), arthralgia (25%), joint pain (17.1%)

Rare (less than 0.1%): Polymyalgia rheumatic, rheumatoid arthritis^[Ref]

Psychiatric

Very common (10% or more): Irritability/fussiness (82%)^[Ref]

Nervous system

Very common (10% or more): Headache (35%), drowsiness (37.8%)

Common (1% to 10%): Dizziness

Rare (less than 0.1%): Convulsion, cerebrovascular accident, cranial nerve IV palsy, facial palsy, radiculitis, febrile convulsion^[Ref]

Other

Very common (10% or more): Fatigue (34%), fever (22.4%), shivering (17%)^[Ref]

Respiratory

Rare (less than 0.1%): Pulmonary embolism, rheumatoid lung^[Ref]

Metabolic

Very common (10% or more): Loss of appetite (29.1%)^[Ref]

Gastrointestinal

Very common (10% or more): Gastrointestinal reaction (nausea, vomiting, diarrhea, and/or abdominal pain) (17.2%)

Common (1% to 10%): Gastroenteritis

Rare (less than 0.1%): Celiac disease, Crohn's disease^[Ref]

Dermatologic

Very common (10% or more): Sweating (11%)

Uncommon (0.1% to 1%): Rash

Rare (less than 0.1%): Psoriasis, erythema nodosum, alopecia^[Ref]

Ocular

Common (1% to 10%): Eye infections

Rare (less than 0.1%): Corneal transplant rejection^[Ref]

Hepatic

Rare (less than 0.1%): Autoimmune hepatitis^[Ref]

Cardiovascular

Rare (less than 0.1%): Temporal arteritis^[Ref]

Oncologic

Rare (less than 0.1%): Thyroid cancer^[Ref]